Golden State Equity Partners’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$126K Sell
529
-4,823
-90% -$1M 0.34% 41
2026
Q1
$1.13M Buy
5,352
+2,313
+76% +$498K 0.09% 265
2025
Q4
$624K Buy
3,039
+57
+2% +$10.7K 0.1% 232
2025
Q3
$468K Buy
2,982
+97
+3% +$15K 0.08% 270
2025
Q2
$485K Sell
2,885
-261
-8% -$38.7K 0.09% 249
2025
Q1
$433K Buy
+3,146
New +$401K 0.09% 273
2024
Q3
Sell
-4,229
Closed -$416K 825
2024
Q2
$416K Buy
+4,229
New +$431K 0.09% 256

Other funds holding CAH

Golden State Equity Partners's CAH Position: Q2 2026 in Review

Golden State Equity Partners reduced its Cardinal Health (CAH) stake by 90% in Q2 2026, selling an estimated $1M and leaving 529 shares worth $126K. The position accounts for 0.34% of the portfolio, ranked #41.

Golden State Equity Partners first reported a position in CAH in Q2 2024 and has held it in 7 quarters since. The position peaked at $1.13M in Q1 2026. 795 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Golden State Equity Partners held 529 shares of Cardinal Health worth $126K as of Q2 2026.
  • Golden State Equity Partners sold 4,823 Cardinal Health shares in Q2 2026, an estimated $1M.
  • Cardinal Health made up 0.34% of Golden State Equity Partners's portfolio in Q2 2026, its #41 holding.
  • Golden State Equity Partners first reported a position in Cardinal Health in Q2 2024 and has held it in 7 quarters since.
  • Golden State Equity Partners's Cardinal Health position peaked at $1.13M in Q1 2026.
  • 795 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Golden State Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.